Overview
Jikun Feng practices practicing medicine in Guangzhou, China.
Feng is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Triple-Negative Breast Cancer, Breast Cancer, and BRCA Positive Breast Cancer.
They are actively involved in clinical research, co-authoring 15 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Jikun Feng
Is Jikun Feng a top-rated expert for Triple-Negative Breast Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Jikun Feng is classified as an Advanced expert for Triple-Negative Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Jikun Feng participate in research or clinical trials?
Yes. Jikun Feng has published 15 articles and abstracts on conditions like Triple-Negative Breast Cancer. You can view a list of Jikun Feng's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Triple-Negative Breast Cancer
- Experienced
- BRCA Positive Breast CancerFeng isExperienced. Learn about BRCA Positive Breast Cancer.
- Breast CancerFeng isExperienced. Learn about Breast Cancer.